{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:09:02Z","timestamp":1791133742612,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bcp.2005.04.043","type":"journal-article","created":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T13:34:03Z","timestamp":1121434443000},"page":"700-713","source":"Crossref","is-referenced-by-count":390,"title":["Curcumin (diferuloylmethane) inhibits constitutive NF-\u03baB activation, induces G1\/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma"],"prefix":"10.1016","volume":"70","author":[{"given":"Shishir","family":"Shishodia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat B.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2005.04.043_bib1","series-title":"Pathology and genetics of tumors of haematopoietic and lymphoid tissues","first-page":"168","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2001"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib2","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.bcp.2005.04.043_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","article-title":"Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group","volume":"64","author":"Weisenburger","year":"2000","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.bcp.2005.04.043_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","article-title":"Mantle cell lymphoma: a retrospective study of 121 cases","volume":"12","author":"Samaha","year":"1998","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bcp.2005.04.043_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hon.2900070505","article-title":"Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis","volume":"7","author":"Meusers","year":"1989","journal-title":"Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bcp.2005.04.043_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1083-8791(00)70030-9","article-title":"Autologous hematopoietic stem cell transplantation for mantle cell lymphoma","volume":"6","author":"Vose","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","article-title":"European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma","volume":"18","author":"Foran","year":"2000","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bcp.2005.04.043_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2000.18.4.773","article-title":"Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma","volume":"18","author":"Zinzani","year":"2000","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.bcp.2005.04.043_bib9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0959-8049(02)00143-0","article-title":"Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma","volume":"38","author":"Rummel","year":"2002","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2005.04.043_bib10","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V81.11.3063.3063","article-title":"Rearrangement and overexpression of the BCL-1\/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias","volume":"81","author":"Rimokh","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib11","first-page":"519","article-title":"Coding sequence of the overexpressed transcript of the putative oncogene PRAD1\/cyclin D1 in two primary human tumors","volume":"8","author":"Rosenberg","year":"1993","journal-title":"Oncogene"},{"issue":"4656","key":"10.1016\/j.bcp.2005.04.043_bib12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bcp.2005.04.043_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-2141.2003.04121.x","article-title":"Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma","volume":"120","author":"Nagy","year":"2003","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.bcp.2005.04.043_bib14","first-page":"8226","article-title":"The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival","volume":"63","author":"Martinez","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bcp.2005.04.043_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5483\/BMBRep.2002.35.1.028","article-title":"Nuclear factor-kappa B activation: a question of life and death","volume":"35","author":"Shishodia","year":"2002","journal-title":"J Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib16","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1016\/S0960-9822(06)00046-7","article-title":"Activate NF-kappa B or die?","volume":"7","author":"Baichwal","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/j.bcp.2005.04.043_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0065-2776(08)60742-7","article-title":"NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules","volume":"65","author":"Baeuerle","year":"1997","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bcp.2005.04.043_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"42","key":"10.1016\/j.bcp.2005.04.043_bib19","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]","volume":"270","author":"Singh","year":"1995","journal-title":"J Biol Chem"},{"issue":"1A","key":"10.1016\/j.bcp.2005.04.043_bib20","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.bcp.2005.04.043_bib21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2141.1998.00911.x","article-title":"Establishment and characterization of a mantle cell lymphoma cell line","volume":"102","author":"Jeon","year":"1998","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.bcp.2005.04.043_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line","volume":"26","author":"Lai","year":"2002","journal-title":"Mino Leuk Res"},{"issue":"6","key":"10.1016\/j.bcp.2005.04.043_bib23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1097-0142(19890915)64:6<1248::AID-CNCR2820640614>3.0.CO;2-5","article-title":"The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma","volume":"64","author":"Daibata","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2005.04.043_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0076-6879(00)19055-X","article-title":"Assay for redox-sensitive transcription factor","volume":"319","author":"Chaturvedi","year":"2000","journal-title":"Meth Enzymol"},{"issue":"15","key":"10.1016\/j.bcp.2005.04.043_bib25","first-page":"4375","article-title":"Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1","volume":"63","author":"Shishodia","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bcp.2005.04.043_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","article-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","volume":"101","author":"Bharti","year":"2003","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.bcp.2005.04.043_bib27","first-page":"3838","article-title":"Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase","volume":"60","author":"Manna","year":"2000","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.bcp.2005.04.043_bib28","doi-asserted-by":"crossref","first-page":"13245","DOI":"10.1074\/jbc.273.21.13245","article-title":"Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1","volume":"273","author":"Manna","year":"1998","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bcp.2005.04.043_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Amin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.bcp.2005.04.043_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.bcp.2005.04.043_bib31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81064-8","article-title":"Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity","volume":"84","author":"Chen","year":"1996","journal-title":"Cell"},{"issue":"6748","key":"10.1016\/j.bcp.2005.04.043_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/43466","article-title":"NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase","volume":"401","author":"Ozes","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2005.04.043_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0092-8674(91)90101-4","article-title":"Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle","volume":"65","author":"Matsushime","year":"1991","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.bcp.2005.04.043_bib34","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/sj.onc.1202581","article-title":"Caspases: the proteases of the apoptotic pathway","volume":"17","author":"Nunez","year":"1998","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.bcp.2005.04.043_bib35","doi-asserted-by":"crossref","first-page":"15096","DOI":"10.1074\/jbc.M311192200","article-title":"Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis","volume":"279","author":"Takada","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bcp.2005.04.043_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.bcp.2005.04.043_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/172460089901400308","article-title":"Blood concentrations of tumor necrosis factor-alpha in malignant lymphomas and their decrease as a predictor of disease control in response to low-dose subcutaneous immunotherapy with interleukin-2","volume":"14","author":"Lissoni","year":"1999","journal-title":"Int J Biol Markers"},{"issue":"44","key":"10.1016\/j.bcp.2005.04.043_bib38","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1038\/sj.onc.1202980","article-title":"Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK\/IKK signalling complex","volume":"18","author":"Plummer","year":"1999","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bcp.2005.04.043_bib39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0006-2952(00)00489-5","article-title":"Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages","volume":"60","author":"Pan","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.bcp.2005.04.043_bib40","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.semcdb.2004.01.002","article-title":"PI 3-kinase, Akt and cell survival","volume":"15","author":"Downward","year":"2004","journal-title":"Semin Cell Dev Biol"},{"issue":"49","key":"10.1016\/j.bcp.2005.04.043_bib42","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.bcp.2005.04.043_bib43","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1128\/MCB.21.24.8428-8436.2001","article-title":"The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition","volume":"21","author":"Westerheide","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"20","key":"10.1016\/j.bcp.2005.04.043_bib44","first-page":"6666","article-title":"Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2","volume":"63","author":"Heckman","year":"2003","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.bcp.2005.04.043_bib45","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1073\/pnas.94.22.11758","article-title":"IkappaB kinase: beginning, not the end","volume":"94","author":"Verma","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.bcp.2005.04.043_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.10139","article-title":"Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases","volume":"70","author":"Agarwal","year":"2002","journal-title":"Am J Hematol"},{"issue":"22","key":"10.1016\/j.bcp.2005.04.043_bib47","doi-asserted-by":"crossref","first-page":"14008","DOI":"10.1074\/jbc.273.22.14008","article-title":"Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T-cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates","volume":"273","author":"Giri","year":"1998","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.bcp.2005.04.043_bib48","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V94.8.2844.420k43_2844_2853","article-title":"Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells","volume":"94","author":"Estrov","year":"1999","journal-title":"Blood"},{"issue":"57","key":"10.1016\/j.bcp.2005.04.043_bib49","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1038\/sj.onc.1206048","article-title":"Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation","volume":"21","author":"Mukhopadhyay","year":"2002","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.bcp.2005.04.043_bib50","first-page":"5499","article-title":"Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors","volume":"56","author":"Voorzanger","year":"1996","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bcp.2005.04.043_bib51","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.V94.6.2080","article-title":"Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas","volume":"94","author":"Kossakowska","year":"1999","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bcp.2005.04.043_bib52","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Giuliani","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2005.04.043_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2141.2002.03417.x","article-title":"RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma","volume":"117","author":"Roux","year":"2002","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V99.2.634","article-title":"Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells","volume":"99","author":"Nosaka","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2005.04.043_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2141.2001.03102.x","article-title":"Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis","volume":"115","author":"Ni","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bcp.2005.04.043_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/carcin\/23.1.143","article-title":"Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl","volume":"23","author":"Anto","year":"2002","journal-title":"Carcinogenesis"},{"issue":"52","key":"10.1016\/j.bcp.2005.04.043_bib57","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1038\/sj.onc.1204997","article-title":"Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines","volume":"20","author":"Mukhopadhyay","year":"2001","journal-title":"Oncogene"},{"issue":"4B","key":"10.1016\/j.bcp.2005.04.043_bib58","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205002418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205002418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T16:45:03Z","timestamp":1626194703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295205002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0006295205002418"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2005.04.043","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}